Summary
Updated Aug 31, 2026
Foundation Fighting Blindness Retinal Degeneration Fund is Director of Opus Genetics, Inc. (IRD). 2 SEC Form 4 filings on record going back to 2025, most recently on 20 May 2026. Most recent open-market trade: sold $7.39M of IRD on 20 May 2026. Lifetime open-market sales: $7.39M.
Recent Transactions
2Every recent SEC Form 4 transaction Foundation Fighting Blindness Retinal Degeneration Fund has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Foundation Fighting Blindness Retinal Degeneration Fund go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Foundation Fighting Blindness Retinal Degeneration Fund files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Cam Gallagher - $324K of IRD open-market activity in the last 12 months
- George Magrath - $205K of IRD open-market activity in the last 12 months
- Robert E. Gagnon - $64K of IRD open-market activity in the last 12 months
- Benjamin R. Yerxa - $61K of IRD open-market activity in the last 12 months
- Ashwath Jayagopal - $58K of IRD open-market activity in the last 12 months
- Joseph K. Schachle - $58K of IRD open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is Foundation Fighting Blindness Retinal Degeneration Fund?
Foundation Fighting Blindness Retinal Degeneration Fund is a trust, tracked as Director of Opus Genetics, Inc. (IRD). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Foundation Fighting Blindness Retinal Degeneration Fund last file a Form 4?
The most recent primary Form 4 on record is dated 20 May 2026, one of 2 filings going back to 2025.
Has Foundation Fighting Blindness Retinal Degeneration Fund been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($7.39M) across all tracked filings.
Where can I see all of Foundation Fighting Blindness Retinal Degeneration Fund's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Foundation Fighting Blindness Retinal Degeneration Fund and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial